Amphastar Pharmaceuticals SG&A Expense (TTM) Analysis

Amphastar Pharmaceuticals Inc (AMPH)

37.38 -0.37 (-0.98%) USD | NASDAQ | Jul 08, 16:00

37.38 0.00 (0.00%) After-Hours: 18:58

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	84.85M
December 31, 2023	80.39M
September 30, 2023	74.75M
June 30, 2023	72.46M
March 31, 2023	69.20M
December 31, 2022	66.59M
September 30, 2022	65.19M
June 30, 2022	64.08M
March 31, 2022	67.03M
December 31, 2021	68.92M
September 30, 2021	70.04M
June 30, 2021	69.74M
March 31, 2021	70.99M
December 31, 2020	65.16M
September 30, 2020	63.32M
June 30, 2020	62.21M
March 31, 2020	57.68M
December 31, 2019	63.11M
September 30, 2019	65.54M
June 30, 2019	66.67M
March 31, 2019	64.79M

Date	Value
December 31, 2018	58.04M
September 30, 2018	52.48M
June 30, 2018	50.54M
March 31, 2018	50.82M
December 31, 2017	50.92M
September 30, 2017	52.26M
June 30, 2017	50.93M
March 31, 2017	47.89M
December 31, 2016	47.30M
September 30, 2016	45.12M
June 30, 2016	43.24M
March 31, 2016	45.22M
December 31, 2015	46.97M
September 30, 2015	48.22M
June 30, 2015	49.03M
March 31, 2015	46.24M
December 31, 2014	40.37M
September 30, 2014	38.40M
June 30, 2014	38.40M
March 31, 2014	36.12M
December 31, 2013	36.32M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

57.68M

Minimum

Mar 2020

84.85M

Maximum

Mar 2024

68.49M

Average

67.03M

Median

Mar 2022

SG&A Expense (TTM) Benchmarks